Allarity Therapeutics (ALLR) Current Leases (2020 - 2022)
Allarity Therapeutics' (ALLR) quarterly Current Leases came in at $8000.0 in Q4 2022, down 91.84% YoY from $98000.0 in Q4 2021, and down 72.41% on a QoQ basis from $29000.0 in Q3 2022.
Allarity Therapeutics (ALLR) Current Leases (2020 - 2022) Analysis & Trends
Allarity Therapeutics (ALLR) has 3 years of Current Leases data on file, last reported at $8000.0 in Q4 2022.
- Quarterly Current Leases fell 91.84% year-over-year to $8000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $8000.0 (down 91.84% YoY) and the FY2022 annual result came in at $8000.0, down 91.84% from the prior year.
- Current Leases eased to $8000.0 in Q4 2022, from $29000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $109000.0 in Q4 2020 to a low of $8000.0 in Q4 2022.
- A 3-year average of $68285.7 and a median of $82000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases decreased 10.09% — and 2022, when it plunged 91.84%.
- Tracing ALLR's Current Leases over 3 years: stood at $109000.0 in 2020, then retreated by 10.09% to $98000.0 in 2021, then sank by 91.84% to $8000.0 in 2022.
- The last three Current Leases figures came in at $8000.0 (Q4 2022), $29000.0 (Q3 2022), and $54000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 98,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Dec 31, 2020 | 109,000.00 |